Review History


All reviews of published articles are made public. This includes manuscript files, peer review comments, author rebuttals and revised materials. Note: This was optional for articles submitted before 13 February 2023.

Peer reviewers are encouraged (but not required) to provide their names to the authors when submitting their peer review. If they agree to provide their name, then their personal profile page will reflect a public acknowledgment that they performed a review (even if the article is rejected). If the article is accepted, then reviewers who provided their name will be associated with the article itself.

View examples of open peer review.

Summary

  • The initial submission of this article was received on April 29th, 2024 and was peer-reviewed by 2 reviewers and the Academic Editor.
  • The Academic Editor made their initial decision on June 4th, 2024.
  • The first revision was submitted on June 14th, 2024 and was reviewed by the Academic Editor.
  • The article was Accepted by the Academic Editor on June 17th, 2024.

Version 0.2 (accepted)

· Jun 17, 2024 · Academic Editor

Accept

The minor corrections have been addressed and the manuscript is accepted.

Version 0.1 (original submission)

· Jun 4, 2024 · Academic Editor

Minor Revisions

Based on the reviewers, a minor revision is needed

Reviewer 1 ·

Basic reporting

1. Clarity and language
The manuscript is written okay, using clear, professional English throughout. However, there are a number of areas where the language could be further improved to increase clarity. Specific examples include:
Line 17: “Stage IV colorectal cancer (CRC) patients need an appropriate indicator for prognosis, because treatment plan is determined by the prognosis. “ This sentence can be rephrased to improve flow and readability.
Line 42: “If the good prognosis group and the poor prognosis group can be selected, more effective treatment can be performed.” Consider rephrasing for clarity. clarity.
There are other good similarities, so please revise the entire text completely. Consider having another fluent English speaker or professional editing service review the manuscript.

2. Structure, graphics, and data sharing
The description of the “Methods of Histological Analysis” in the article has a certain level of detail, but could be further improved to increase reproducibility and clarity. This includes describing detailed staining procedures such as staining time, concentration, temperature, etc., and describing how different types of features are identified and categorized.

Experimental design

1. relevance to the scope of the journal: the study fits well within the scope of PeerJ and addresses an important issue in the field of oncology and pathology.

2. methodological details:
Provide more details about the Kaplan-Meier and Cox proportional risk models used, e.g., describe how cases with identical survival times are treated, e.g., whether adjusted Kaplan-Meier curves are used; illustrate how the Cox proportional risk model handles missing data and outliers.

3 Implications and novelty
The content and conclusions of this paper are not considered novel, but the good thing is that the data, methods and conclusions are SOLID.

Validity of the findings

1. Strengths and advantages
Large sample size and long-term follow-up to obtain data

Additional comments

This paper is relatively simple in content, data and analysis, but overall it seems to be fine. The conclusions also make sense, with a large amount of data supporting the different prognostic outcomes for different histologic types.

Reviewer 2 ·

Basic reporting

1. The writing in this paper needs to be carefully improved.
2. In table 1, it should be ‘gender’, not ‘gander’.

Experimental design

1. For the use of Cox proportional hazards model, the proportional hazards assumption needs to be tested (such as evaluating Schoenfeld residuals to examine validity of the proportional hazards assumption).
2. A table 1 with distribution of baseline characteristics (eg demographics, health conditions) should be provided, along with providing a description of the loss to follow up rate (for the 5-year follow-up mentioned).

Validity of the findings

No comment.

All text and materials provided via this peer-review history page are made available under a Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.